MoneyWorks4Me

Zydus Lifesciences informs about press release

22 Jan 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated January 22, 2026, titled ‘Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha™’, in India to treat multiple cancers’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.00
Dr. Reddys Labs. 1313.30
Cipla 1324.20
Lupin 1948.30
Zydus Lifesciences 1165.50
View more..